business
Move Over AI: Jeff Bezos and NVIDIA Are Quietly Backing a New Breakthrough Industry
Key takeaways
- Jeff Bezos reportedly committed $3 billion to longevity startup Altos Labs, while Brian Armstrong s New Limit tripled in value to $3 billion.
- Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Eli Lilly didn t make the cut.
- Over recent months, a striking pattern has emerged: major capital allocators are positioning around AI-driven biology and longevity.
Move Over AI: Jeff Bezos and NVIDIA Are Quietly Backing a New Breakthrough Industry David Moadel Wed, June 3, 2026 at 11:22 PM GMT+7 4 min read NVDA LLY POLA.PVT AMZN COIN Quick Read NVIDIA and Eli Lilly s $1 billion AI drug discovery partnership makes both stocks the primary public vehicles for programmable biology exposure.
Jeff Bezos reportedly committed $3 billion to longevity startup Altos Labs, while Brian Armstrong s New Limit tripled in value to $3 billion.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Eli Lilly didn t make the cut. Grab the names FREE today.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop